Comparative genomic hybridization and loss of heterozygosity analyses identify a common region of deletion at 15q11.1-15 in Human malignant mesothelioma

Cancer Research

Volumn 59, Issue 2, 1999, Pages 450-454

  Balsara, Binaifer R ^a   Bell, Daphne W ^a   Sonoda, Gonosuke ^a   De Rienzo, Assunta ^a   Du Manoir, Stanislas ^b   Jhanwar, Suresh C ^c   Testa, Joseph R ^a  

^a FOX CHASE CANCER CENTER   (United States)

^b INSERM   (France)

^c MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MICROSATELLITE DNA;

ARTICLE; CHROMOSOME 15Q; CHROMOSOME MAP; COMPARATIVE GENOMIC HYBRIDIZATION; DELETION MUTANT; DNA SEQUENCE; GENE INACTIVATION; GENETIC ANALYSIS; HETEROZYGOSITY LOSS; HUMAN; HUMAN CELL; KARYOTYPE; MALIGNANT MESOTHELIOMA; PATHOGENESIS; PRIORITY JOURNAL; TUMOR SUPPRESSOR GENE;

CHROMOSOMES, HUMAN, PAIR 15; DNA-BINDING PROTEINS; HUMANS; LOSS OF HETEROZYGOSITY; MESOTHELIOMA; NUCLEIC ACID HYBRIDIZATION; RAD51 RECOMBINASE; TUMOR CELLS, CULTURED;

EID: 0033555622     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Attanoos, R. L., and Gibbs, A. R. Pathology of malignant mesothelioma. Histopathology, 30: 403-418, 1997.
2. Popescu, N. C., Chahinian, A. P., and DiPaolo, J. A. Nonrandom chromosome alterations in human malignant mesothelioma. Cancer Res., 48: 142-147, 1988.
3. Tiainen, M., Tammilehto, L., Rautonen, J., Tuomi, T., Mattson, K., and Knuutila, S. Chromosomal abnormalities and their correlations with asbestos exposure and survival in patients with mesothelioma. Br. J. Cancer, 60: 618-626, 1989.
4. Flejter, W. L., Li, F. P., Antman, K. H., and Testa, J. R. Recurring loss involving chromosomes 1, 3 and 22 in malignant mesothelioma: possible sites of tumor suppressor genes. Genes Chromosomes Cancer, 1: 148-154, 1989.
5. Taguchi, T., Jhanwar, S. C., Siegfried, J. M. Keller, S. M., and Testa, J. R. Recurrent deletions of specific chromosomal sites in 1p, 3p, 6q, and 9p in human malignant mesothelioma. Cancer Res., 53: 4349-4355, 1993.
6. Bell, D. W., and Testa, J. R. Tumor suppressor genes in malignant mesothelioma. In: G. A. Peters and B. J. Peters (eds.), Asbestos and Cancer, Vol. 16, pp. 99-126. Charlottesville, VA: LEXIS Law, 1997.
7. Cheng, J. Q., Jhanwar, S. C., Klein, W. M., Bell, D. W., Lee, W. C., Altomare, D. A., Nobori, T., Olopade, O. I., Buckler, A. J., and Testa, J. R. p16 alterations and deletion mapping of 9p21-p22 in malignant mesothelioma. Cancer Res., 54: 5547-5551, 1994.
8. Sekido, Y., Pass, H. I., Bader, S., Mew, D. J., Christman, M. F., Gazdar, A. F., and Minna, J. D. Neurofibromatosis type 2 (NF2) gene is somatically mutated in mesothelioma but not in lung cancer. Cancer Res., 55: 1227-1231, 1995.
9. Bianchi, A. B., Mitsunaga, S. I., Cheng, J. Q., Klein, W. M. Jhanwar, S. C., Seizinger, B., Kley, N., Klein-Szanto, A. J., and Testa, J. R. High frequency of inactivating mutations in the neurofibromatosis type 2 gene (NF2) in primary malignant mesotheliomas. Proc. Natl. Acad. Sci. USA, 92: 10854-10858, 1995.
10. Kallioniemi, A., Kallioniemi, O. P., Sudar, D., Rutovitz, D., Gray, J. W., Waldman, F., and Pinkel, D. Comparative genomic hybridization for molecular cytogenetic analysis of solid tumors. Science (Washington DC), 258: 818-821, 1992.
11. Bjorkqvist, A. M., Tammilehto, L., Nordling, S., Nurminen, M., Anttila, S., Mattson, K., and Knuutila, S. Comparison of DNA copy number changes in malignant mesothelioma, adenocarcinoma and large-cell anaplastic carcinoma of the lung. Br. J. Cancer, 77: 260-269, 1998.
12. Bjorkqvist, A. M., Tammilehto, L., Anttila, S., Mattson, K., and Knuutila, S. Recurrent DNA copy number changes in 1q, 4q, 6q, 9p, 13q, 14q and 22q detected by comparative genomic hybridization in malignant mesothelioma. Br. J. Cancer, 75: 523-527, 1997.
13. Sonoda, G., Palazzo, J., du Manoir, S., Godwin, A. K., Feder, M., Yakushiji, M., and Testa, J. R. Comparative genomic hybridization detects frequent overrepresentation of chromosomal material from 3q26, 8q25, and 20q13 in human ovarian carcinomas. Genes Chromosomes Cancer, 20: 320-328, 1997.
14. du Manoir, S., Schrock, E., Bentz, M., Speicher, M. R., Joos, S., Ried, T., Lichter, P., and Cremer, T. Quantitative analysis of comparative genomic hybridization. Cytometry, 19: 27-41, 1995.
15. Bell, D. W., Jhanwar, S. C., and Testa, J. R. Multiple regions of allelic loss from chromosome arm 6q in malignant mesothelioma. Cancer Res., 57: 4057-4062, 1997.
16. Testa, J. R., Carbone, M., Hirvonen, A., Khalili, K., Krynska, B., Linnainmaa, K., Pooley, F. D., Rizzo, P., Rusch, V., and Xiao, G-H. A multi-institutional study confirms the presence and expression of simian virus 40 in human malignant mesotheliomas. Cancer Res., 58: 4505-4509, 1998.
17. Lee, W. C., Balsara, B., Liu, Z., Jhanwar, S. C., and Testa, J. R. Loss of heterozygosity analysis defines a critical region in chromosome 1p22 commonly deleted in human malignant mesothelioma. Cancer Res., 56: 4297-4301, 1996.
18. Meloni, A. M., Stephenson, C. F., Li, F. P., and Sandberg, A. A. del(6q) as a possible primary change in malignant mesothelioma. Cancer Genet. Cytogenet., 59: 57-61, 1992.
19. Cher, M. L., Bova, G. S., Moore, D. H., Small, E. J., Carroll, P. R., Pin, S. S., Epstein, J. I., Isaacs, W. B., and Jensen, R. H. Genetic alterations in untreated metastases and androgen-independent prostate cancer detected by comparative genomic hybridization and allelotyping. Cancer Res., 56: 3091-3102, 1996.
20. Osborne, R. J., and Leech, V. Polymerase chain reaction allelotyping of human ovarian cancer. Br. J. Cancer, 69: 429-438, 1994.
21. Tahara, H., Smith, A. P., Gas, R. D., Cryns, V. L., and Arnold, A. Genomic localization of novel candidate tumor suppressor gene loci in human parathyroid adenomas. Cancer Res., 56: 599-605, 1996.
22. Wick, W., Petersen, I., Schmutzler, R. K., Wolfarth, B., Lenartz, D., Bierhoff, E., Hummerich, J., Muller, D. J., Stangl, A. P., Schramm, J., Wiestler, O. D., and von Deimling, A. Evidence for a novel tumor suppressor gene on chromosome 15 associated with progression to a metastatic stage in breast cancer. Oncogene 12: 973-978, 1996.
23. Lim, D., and Hasty, P. A mutation in mouse rad51 results in an early embryonic lethal that is suppressed by a mutation in p53. Mol. Cell. Biol., 16: 7133-7143, 1996.
24. Sharan, S. K., Morimatsu, M., Albrecht, U., Lim, D. S., Regel, E., Dinh, C., Sands, A., Eichele, G., Hasty, P., and Bradley, A. Embryonic lethality and radiation hypersensitivity mediated by Rad51 in mice lacking Brca2. Nature (Lond.), 386: 804-810, 1997.
25. Balsara, B. R., Sonoda, G., du Manoir, S., Siegfried, J. M., Gabrielson, E., and Testa, J. R. Comparative genomic hybridization analysis detects frequent, often high-level, overrepresentation of DNA sequences at 3q, 5p, 7p, and 8q in human non-small cell lung carcinomas. Cancer Res., 57: 2116-2120, 1997.
26. Speicher, M. R., Howe, C., Crotty, P., du Manoir, S., Costa, J., and Ward, D. C. Comparative genomic hybridization detects novel deletions and amplifications in head and neck squamous cell carcinomas. Cancer Res., 55: 1010-1013, 1995.
27. Gang, H., Kobayashi, R., Galaktionov, K., and Beach, D. p19Skp1 and p45Skp2 are essential elements of the cyclin A-CDK2 S phase kinase. Cell, 82: 915-925, 1995.
28. Kivipensas, P., Bjorkqvist, A. M., Karhu, R., Pelin, K., Linnainmaa, K., Tammilehto, L., Mattson, K., Kallioniemi, O. P., and Knuutila, S. Gains and losses of DNA sequences in malignant mesothelioma by comparative genomic hybridization. Cancer Genet. Cytogenet., 89: 7-13, 1996.